CORMEDIX : REPORTS fourth QUARTER and full year 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE - Form 8-K

CORMEDIX INC. REPORTS fourth QUARTER and full year 2021 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE


Conference Call Scheduled for Today at 4:30 p.m. Eastern Time

... | March 29, 2022

Related Keywords

Defencath Neutrolin ,Matt David ,Joseph Todisco ,Cormedix Inc ,Nasdaq ,Call Scheduled ,Corporate Highlights ,Chief Executive Officer ,Cormedix Board ,Chief Commercial Officer ,Webcast Link ,Fast Track ,Qualified Infectious Disease Product ,New Drug Application ,New Chemical Entity ,Complete Response Letter ,Private Securities Litigation Reform Act ,Three Months Ended ,From Operations ,Per Common Share ,Average Common Shares Outstanding ,Ended December ,Flows From Operating Activities ,Flows Used In Investing Activities ,Flows From Financing Activities ,Cash Equivalents ,Restricted Cash ,Cormedix Inc Stock Exchange ,News ,Information ,Press Release ,Cormedix ,Reports ,Fourth ,Quarter ,End ,Bull ,Ear ,021 ,Financial ,Results ,Rovides ,Business ,Conference ,Wall ,Cheduled ,Or ,Oday ,It ,Astern Crmd Us21900c3088 ,